ArticleLeukemia2019
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
Belen Lopez-Millan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ArticleLeukemia2019
Belen Lopez-Millan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.